Lisetskiĭ V A, Kaban A P, Liutov B N, Shevchenko N V, Litvinova T S
Klin Khir (1962). 1993(5):38-40.
Tramal, the drug produced by the "Grunenthal" firm (FRG) was used in the treatment of 478 patients with malignant neoplasms. In 24.46% patients, the side effects were noted, which were characteristic of the majority of analgetics and didn't threaten the life. The authors recommend to use Tramal for cupping off the pain syndrome at the postoperative period, and in incurable patients as well.
曲马多，由德国“格兰泰”公司生产的药物，被用于治疗478例恶性肿瘤患者。在24.46%的患者中出现了副作用，这些副作用是大多数镇痛药所共有的，且不危及生命。作者建议在术后阶段以及无法治愈的患者中使用曲马多来缓解疼痛综合征。
